Current problems in the first-line treatment of metastatic breast cancer: focus on the role of docetaxel
Metastatic breast cancer is a very heterogeneous disease, both from a clinical and a biological point of view. Despite being still incurable, the expanding therapeutic repertoire has determined a progressive increase in median survival. We describe the clinical course of a 67-year-old woman with a l...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SEEd
2010-09-01
|
| Series: | Clinical Management Issues |
| Subjects: | |
| Online Access: | https://journals.seedmedicalpublishers.com/index.php/cmi/article/view/526 |